Literature DB >> 14618358

[Daytime running light: pros and cons].

B Lachenmayr1.   

Abstract

Daytime running light (DRL) has been in use for many decades in various countries world-wide. Experience is present from the Scandinavian countries, from Canada and the United States. DRL reduces traffic accidents tremendously and encompasses all participants in road traffic, especially the non-motorized pedestrians and cyclists. Physiological-optical considerations, the technical realisation of DRL and accident statistics will be discussed.

Entities:  

Mesh：

Year:  2003        PMID： 14618358     DOI： 10.1007/s00347-002-0755-1

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN： 0941-293X            Impact factor:   1.059


  7 in total

1.  Changes in the legislation on the use of daytime running lights by motor vehicles and their effect on road safety in Hungary.

Authors:  P Holló
Journal:  Accid Anal Prev       Date:  1998-03

2.  A meta-analysis of studies concerning the safety effects of daytime running lights on cars.

Authors:  R Elvik
Journal:  Accid Anal Prev       Date:  1996-11

3.  [Significance of peripheral vision for automobile drivers].

Authors:  B Lachenmayr
Journal:  Fortschr Ophthalmol       Date:  1986

4.  [Driving with light during the day?].

Authors:  B Lachenmayr
Journal:  Ophthalmologe       Date:  1995-02       Impact factor: 1.059

5.  The effect of daytime running lights on crashes between two vehicles in Saskatchewan: a study of a government fleet.

Authors:  G A Sparks; R D Neudorf; A E Smith; K R Wapman; P L Zador
Journal:  Accid Anal Prev       Date:  1993-10

6.  [What visual information does the automobile driver need for safe driving in street traffic?].

Authors:  B Lachenmayr; A Buser; S Müller
Journal:  Ophthalmologe       Date:  1994-06       Impact factor: 1.059

7.  [Inhibition of the saccadic system by a visual load].

Authors:  B Lachenmayr
Journal:  Fortschr Ophthalmol       Date:  1983
  7 in total
  1 in total

1.  [Classification of biomedical research reports as a reference for evidence-based medicine in ophthalmology. A survey considering as example the journal Der Ophthalmologe].

Authors:  H P N Scholl; M Fleckenstein; T U Krohne; F G Holz
Journal:  Ophthalmologe       Date:  2005-12       Impact factor: 1.059
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.